NKTR icon

Nektar Therapeutics
NKTR

Overview Fund Activity

228 hedge funds and large institutions have $561M invested in Nektar Therapeutics in 2022 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 69 increasing their positions, 73 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
228
Holders Change
+3
Holders Change %
+1.33%
% of All Funds
3.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
69
Reduced
73
Closed
25
Calls
$2M
Puts
$219K
Net Calls
+$1.78M
Net Calls Change
-$1.41M

Top Buyers

1
BlackRock
1
BlackRock
New York
$112M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$74.1M
3
Northern Trust
3
Northern Trust
Illinois
$5.98M
4
Jacobs Levy Equity Management
4
Jacobs Levy Equity Management
New Jersey
$3.32M
5
Federated Hermes
5
Federated Hermes
Pennsylvania
$2.68M

Top Sellers

1
First Trust Advisors
1
First Trust Advisors
Illinois
$0
2
MC
2
Maverick Capital
Texas
$0
3
GPP
3
Great Point Partners
Connecticut
$1.43M
4
AllianceBernstein
4
AllianceBernstein
Tennessee
$3.97M
5
State Street
5
State Street
Massachusetts
$25.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
FAIM
226
Financial Advocates Investment Management
Washington
– -$47K -829 Closed
VCG
227
Vantage Consulting Group
Virginia
– -$41K -712 Closed
SA
228
Syntax Advisors
New York
– -$41K -712 Closed
AGM
229
Alpine Global Management
New York
– -$39K -680 Closed
MCIA
230
Mountain Capital Investment Advisors
Colorado
– -$39K -667 Closed
SIAP
231
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
– -$2K -37 Closed
FBC
232
Fairfield, Bush & Co
Connecticut
– -$1K -13 Closed
6 7 8 9
10